In comparison, by incorporation of GRK5 deficiency that is known to be an AD-related factor8, 12, 30, it recapitulates the typical AD change of BFC neuronal loss, thus validating the cholinergic hypothesis, and enabling the relevant mechanistic and therapeutic studies. The gene discussed is GRK5; the disease is Alzheimer disease.